Metagenomic Methods for Addressing NASA's Planetary Protection Policy Requirements on Future Missions: A Workshop Report.


Journal

Astrobiology
ISSN: 1557-8070
Titre abrégé: Astrobiology
Pays: United States
ID NLM: 101088083

Informations de publication

Date de publication:
08 2023
Historique:
medline: 17 8 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

Molecular biology methods and technologies have advanced substantially over the past decade. These new molecular methods should be incorporated among the standard tools of planetary protection (PP) and could be validated for incorporation by 2026. To address the feasibility of applying modern molecular techniques to such an application, NASA conducted a technology workshop with private industry partners, academics, and government agency stakeholders, along with NASA staff and contractors. The technical discussions and presentations of the Multi-Mission Metagenomics Technology Development Workshop focused on modernizing and supplementing the current PP assays. The goals of the workshop were to assess the state of metagenomics and other advanced molecular techniques in the context of providing a validated framework to supplement the bacterial endospore-based NASA Standard Assay and to identify knowledge and technology gaps. In particular, workshop participants were tasked with discussing metagenomics as a stand-alone technology to provide rapid and comprehensive analysis of total nucleic acids and viable microorganisms on spacecraft surfaces, thereby allowing for the development of tailored and cost-effective microbial reduction plans for each hardware item on a spacecraft. Workshop participants recommended metagenomics approaches as the only data source that can adequately feed into quantitative microbial risk assessment models for evaluating the risk of forward (exploring extraterrestrial planet) and back (Earth harmful biological) contamination. Participants were unanimous that a metagenomics workflow, in tandem with rapid targeted quantitative (digital) PCR, represents a revolutionary advance over existing methods for the assessment of microbial bioburden on spacecraft surfaces. The workshop highlighted low biomass sampling, reagent contamination, and inconsistent bioinformatics data analysis as key areas for technology development. Finally, it was concluded that implementing metagenomics as an additional workflow for addressing concerns of NASA's robotic mission will represent a dramatic improvement in technology advancement for PP and will benefit future missions where mission success is affected by backward and forward contamination.

Identifiants

pubmed: 37102710
doi: 10.1089/ast.2022.0044
pmc: PMC10457625
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

897-907

Références

Nucleic Acids Res. 2013 Jan 7;41(1):e1
pubmed: 22933715
J Microbiol Methods. 2006 Nov;67(2):310-20
pubmed: 16753236
PLoS Comput Biol. 2012;8(10):e1002743
pubmed: 23133348
Front Microbiol. 2021 Sep 28;12:685254
pubmed: 34650522
BMC Bioinformatics. 2020 May 29;21(1):220
pubmed: 32471343
Appl Environ Microbiol. 2007 Apr;73(8):2600-11
pubmed: 17308177
Microbiome. 2021 Dec 4;9(1):238
pubmed: 34861887
Microbiome. 2021 Jan 21;9(1):17
pubmed: 33478576
Astrobiology. 2010 Apr;10(3):325-35
pubmed: 20446872
PeerJ. 2019 Jun 14;7:e7121
pubmed: 31231597
Appl Environ Microbiol. 2002 Oct;68(10):5064-81
pubmed: 12324358
Sci Rep. 2017 Jul 18;7(1):5752
pubmed: 28720878
Appl Environ Microbiol. 2011 May;77(9):2943-53
pubmed: 21398492
Nat Biotechnol. 2021 Apr;39(4):499-509
pubmed: 33169036
Microbiome. 2014 Apr 07;2:11
pubmed: 24708850
Front Microbiol. 2016 Sep 09;7:1321
pubmed: 27667984
Astrobiology. 2014 Jan;14(1):15-23
pubmed: 24432775
Astrobiology. 2013 Feb;13(2):189-202
pubmed: 23421553
ISME J. 2013 Feb;7(2):312-24
pubmed: 23051695
J Biomol Tech. 2017 Apr;28(1):46-55
pubmed: 28344519
Cell. 2019 Aug 8;178(4):779-794
pubmed: 31398336
Microbiome. 2018 Feb 27;6(1):42
pubmed: 29482639
Nat Microbiol. 2018 Aug;3(8):851-853
pubmed: 30046175
Microbiome. 2017 Aug 16;5(1):86
pubmed: 28810907
Appl Environ Microbiol. 2012 Aug;78(16):5912-22
pubmed: 22729532
Appl Environ Microbiol. 2011 Aug;77(15):5438-44
pubmed: 21652744
PeerJ. 2016 Sep 22;4:e2486
pubmed: 27688978
Microbiome. 2018 Nov 13;6(1):204
pubmed: 30424821
Genome Biol. 2007;8(7):R143
pubmed: 17659080
Genome Biol. 2017 Sep 21;18(1):182
pubmed: 28934964
Microbiome. 2021 Apr 1;9(1):82
pubmed: 33795001
Appl Microbiol Biotechnol. 2013 Mar;97(5):2153-62
pubmed: 23354451
Nat Commun. 2018 Nov 23;9(1):4956
pubmed: 30470746
Astrobiology. 2010 Oct;10(8):845-52
pubmed: 21087163
Methods Mol Biol. 2008;439:1-18
pubmed: 18370092
Chem Biol. 1998 Oct;5(10):R245-9
pubmed: 9818143
mSystems. 2018 Mar 13;3(3):
pubmed: 29577086
AMB Express. 2016 Dec;6(1):113
pubmed: 27844457
J Endod. 2020 Nov;46(11):1570-1576
pubmed: 32805336
New Phytol. 2009 Oct;184(2):449-456
pubmed: 19703112
mBio. 2017 Feb 21;8(1):
pubmed: 28223457
Nat Microbiol. 2016 Apr 11;1:16048
pubmed: 27572647
PLoS One. 2014 Apr 08;9(4):e93827
pubmed: 24714158
PLoS One. 2017 Jan 18;12(1):e0169662
pubmed: 28099457
Trends Microbiol. 2019 Feb;27(2):105-117
pubmed: 30497919
PLoS One. 2015 May 21;10(5):e0128122
pubmed: 25996930
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
View (Beijing). 2021 Apr;2(2):20200082
pubmed: 34766158

Auteurs

Stefan J Green (SJ)

Genomics and Microbiome Core Facility, Rush University Medical Center, Chicago, Illinois, USA.

Tamas Torok (T)

Ecology Department, Lawrence Berkeley National Laboratory, Berkeley, California, USA.

Jonathan E Allen (JE)

Lawrence Livermore National Laboratory, Livermore, California, USA.

Emiley Eloe-Fadrosh (E)

DOE Joint Genome Institute, Lawrence Berkeley National Laboratory, Berkeley, California, USA.

Scott A Jackson (SA)

National Institute of Standards and Technology, Gaithersburg, Maryland, USA.

Sunny C Jiang (SC)

Department of Civil and Environmental Engineering, University of California, Irvine, California, USA.

Stuart S Levine (SS)

MIT BioMicro Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Shawn Levy (S)

HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.

Lynn M Schriml (LM)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.

W Kelley Thomas (WK)

Hubbard Center for Genome Studies, University of New Hampshire, Durham, New Hampshire, USA.

Jason M Wood (JM)

Research Informatics Core, University of Illinois at Chicago, Chicago, Illinois, USA.

Scott W Tighe (SW)

Vermont Integrative Genomics, University of Vermont, Burlington, Vermont, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH